Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes. [PDF]
Nichols RH, Chambers JE.
europepmc +1 more source
A-series agent A-234: initial in vitro and in vivo characterization. [PDF]
Hrabinova M +15 more
europepmc +1 more source
Structure-activity studies of bispyridinium antinicotinics to select candidates to treat soman intoxication as part of a combined therapy. [PDF]
Turner SR +7 more
europepmc +1 more source
A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase. [PDF]
Kuca K +12 more
europepmc +1 more source
Central neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates. [PDF]
Chambers JE, Meek EC.
europepmc +1 more source
Design, synthesis, in silico studies and in vitro evaluation of isatin-pyridine oximes hybrids as novel acetylcholinesterase reactivators. [PDF]
Kitagawa DAS +14 more
europepmc +1 more source
Dose-Dependent Tissue Distribution of K117, a Bis-pyridinium Aldoxime, in Rats [PDF]
Barbara Malawska +28 more
core +1 more source
Antidotes in Clinical Toxicology-Critical Review. [PDF]
Kobylarz D +33 more
europepmc +1 more source
Discovery of Novel Non-Oxime Reactivators Showing In Vivo Antidotal Efficiency for Sarin Poisoned Mice. [PDF]
Wei Z +6 more
europepmc +1 more source
Comparison of the reactivation rates of acetylcholinesterase modified by structurally different organophosphates using novel pyridinium oximes. [PDF]
Bharate SB, Chao CK, Thompson CM.
europepmc +1 more source

